Oura's IPO: $16B Valuation Target, $1.4B Revenue, and the Nasdaq Filing Explained

Oura filed a public S-1 on September 3, 2026, disclosing $1.21 billion in nine-month revenue and 5 million paid members — setting up a Nasdaq listing under ticker OURA that bankers are targeting at a valuation above $16 billion.

The filing replaces the confidential draft registration Oura submitted on May 21, 2026, and puts real, audited numbers behind a company most people know only as a ring subscription on their finger. TechCrunch reported the S-1 was led by Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Company, and Jefferies — a five-bank syndicate that signals a large, closely watched offering rather than a quiet listing.

Oura IPO: What the S-1 Actually Discloses

Oura's S-1, filed with the Securities and Exchange Commission on September 3, 2026, shows total revenue of $1.21 billion for the nine months ended June 30, 2026 — up 74% from $697.6 million in the same period a year earlier. Net income came in at $60.77 million, versus just $1.57 million a year prior, and Adjusted EBITDA hit $107 million on a 55% gross margin. The company operates in 56 markets and says its 5 million paid members wear the ring an average of 23 hours a day, generating what it describes as nearly 42 billion cumulative hours of biometric data.

The Valuation Climb: From $2.55B to $16B in Four Years

Oura, founded in 2013 in Oulu, Finland, raised $28 million in a 2020 Series B and $100 million in a 2021 Series C that pushed its valuation to $2.55 billion by 2022. The pace accelerated sharply from there: a $200 million Series D in December 2024, led by Fidelity Management & Research and Dexcom, valued the company at $5.2 billion. Ten months later, a $900 million-plus Series E led by Fidelity — with new investor ICONIQ Growth joining alongside Whale Rock and Atreides — valued Oura at roughly $11 billion, per CNBC. The IPO target of $16 billion-plus would mark another 45% step-up in under a year.

One wrinkle worth flagging: MobiHealthNews reported that a meaningful share of the up to $3 billion offering is structured as existing shareholders selling stock rather than the company raising fresh primary capital. This likely means the IPO functions partly as a liquidity event for Oura's Series B-through-E backers, not purely as growth funding — a distinction that matters for how much of the $16 billion actually lands on Oura's balance sheet versus in early investors' pockets.

How Oura Stacks Up Against the Smart Ring Field

Pricing from company websites and BetterVitals price analysis, September 2026. Market share estimate per industry market-research reporting on 2025 unit share; Oura, Ultrahuman, Renpho, Noise, and Boat together held roughly 85.9% of the category.

Oura's subscription requirement is the frequent criticism in reviews — paying $5.99 a month on top of a $349 ring pushes three-year ownership cost to roughly $559, well above no-subscription rivals like RingConn's $299 flat price. But the membership fee is also exactly why Oura's revenue mix looks like a software business bolted onto a hardware one: a 94%-plus attach rate and 85% 12-month retention on 5 million paying members is what turns a one-time ring sale into a recurring base large enough to justify a $16 billion valuation.

Why Bankers Are Comfortable With a $16B Price Tag

Three numbers do most of the work in justifying Oura's ask. First, growth: 74% year-over-year revenue growth at a $1.4 billion trailing-revenue scale is rare — most consumer-hardware companies decelerate well before nine-figure revenue, let alone ten-figure. Second, profitability: $61 million in net income and $107 million in Adjusted EBITDA over nine months means Oura isn't asking public investors to fund years of future losses, unlike many recent consumer-tech listings. Third, retention: a 94%-plus ring-to-membership conversion rate and 85% 12-month retention across 5 million members is closer to enterprise-SaaS retention economics than typical wearables churn, where competitors report meaningfully higher device abandonment within a year of purchase.

What the headline misses

The $16 billion figure is a target, not a set price — IPO price ranges routinely move 20-30% in either direction once the roadshow gauges real institutional demand, and Oura's own confidential filing in May carried no public valuation attached at all. The global smart ring market is still small in absolute terms (about $1.01 billion in 2026, per Fortune Business Insights estimates, growing toward $7.8 billion by 2035 at a 25.4% CAGR), which means Oura is being priced today at roughly 16x its own trailing revenue and at a multiple of the entire category's current annual size — a bet that Oura keeps expanding beyond rings into broader preventive-health software, not just selling more units of the same device. If Apple, Samsung, or Google decide to compete harder on ring form factor specifically (rather than smartwatches), that thesis gets tested quickly.

The Bottom Line

Oura's September 3, 2026 S-1 turns a decade of Finnish hardware engineering and a Silicon Valley-style subscription attach rate into one of 2026's most closely watched consumer listings. The underlying numbers — $1.4 billion in trailing revenue, 74% growth, and actual GAAP profit — are unusually strong for a hardware IPO, which is exactly why Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Company, and Jefferies are willing to underwrite a $16 billion-plus price tag. Whether that number holds through the roadshow depends less on Oura's past growth than on whether public investors buy the story that a ring company is actually a recurring-revenue health-data business — one large secondary component and all.